Almac Group has created a separate division called Almac Discovery, focussed exclusively on the discovery and development of novel approaches to the treatment of cancer and associated conditions, with the goal of developing a biomarker or diagnostic with each potential new drug. According to the company, projects will generally be taken to clinical proof of concept (or earlier) before out-licensing or partnering for further development. Almac Discovery is looking to build its internal pipeline t...